CytomX Therapeutics, Inc. Change of Control Agreements
11 Contracts & Agreements
- Form of Amended and Restated Severance and Change of Control Agreement by and between CytomX Therapeutics, Inc. and each of its executive officers other than Sean A. McCarthy (Filed With SEC on August 8, 2023)
- Severance and Change of Control Agreement dated March 23, 2020, by and between CytomX Therapeutics, Inc. and Carlos Campoy (Filed With SEC on May 7, 2020)
- Severance and Change of Control Agreement effective as of February 3, 2020, by and between CytomX Therapeutics, Inc. and Alison Hannah, M.D (Filed With SEC on February 27, 2020)
- Severance and Change of Control Agreement effective as of October 14, 2019, by and between CytomX Therapeutics, Inc. and Amy C. Peterson, M.D (Filed With SEC on November 7, 2019)
- Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Debanjan Ray (Filed With SEC on May 9, 2019)
- Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Michael Kavanaugh, M.D (Filed With SEC on May 9, 2019)
- Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Rachel W. Humphrey, M.D (Filed With SEC on May 9, 2019)
- Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Lloyd Rowland (Filed With SEC on May 9, 2019)
- Amended and Restated Severance and Change of Control Agreement dated February 27, 2019, by and between CytomX Therapeutics, Inc. and Sean McCarthy. D. Phil (Filed With SEC on May 9, 2019)
- Severance and Change of Control Agreement, by and between CytomX Therapeutics, Inc. and Lloyd Rowland, dated as of May 16, 2018 (Filed With SEC on August 8, 2018)
- FIRST AMENDMENT TO SEVERANCE AND CHANGE OF CONTROL AGREEMENT (Filed With SEC on March 7, 2016)
